Xu YQ - Search Results

1

sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses.

Zhang CL, Xu YJ, Yang HX, Xu YQ, Shang DS, Wu T, Zhang YP, Li X. Zhang CL, et al. Among authors: xu yj, xu yq. Sci Rep. 2017 Nov 10;7(1):15322. doi: 10.1038/s41598-017-15631-y. Sci Rep. 2017. PMID: 29127397 Free PMC article.

2

LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies.

Xu Y, Li F, Wu T, Xu Y, Yang H, Dong Q, Zheng M, Shang D, Zhang C, Zhang Y, Li X. Xu Y, et al. Oncotarget. 2017 Feb 28;8(9):15453-15469. doi: 10.18632/oncotarget.14973. Oncotarget. 2017. PMID: 28152521 Free PMC article.

3

BioM2MetDisease: a manually curated database for associations between microRNAs, metabolites, small molecules and metabolic diseases.

Xu Y, Yang H, Wu T, Dong Q, Sun Z, Shang D, Li F, Xu Y, Su F, Liu S, Zhang Y, Li X. Xu Y, et al. Database (Oxford). 2017 Jan 1;2017:bax037. doi: 10.1093/database/bax037. Database (Oxford). 2017. PMID: 28605773 Free PMC article.

4

Integrating gene and lncRNA expression to infer subpathway activity for tumor analyses.

Zhang C, Xu Y, Yang H, Xu Y, Dong Q, Liu S, Wu T, Zhang Y. Zhang C, et al. Oncotarget. 2017 Nov 30;8(67):111433-111443. doi: 10.18632/oncotarget.22811. eCollection 2017 Dec 19. Oncotarget. 2017. PMID: 29340065 Free PMC article.

5

Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.

Wang L, Zhao H, Xu Y, Li J, Deng C, Deng Y, Bai J, Li X, Xiao Y, Zhang Y. Wang L, et al. Int J Cancer. 2019 Apr 1;144(7):1723-1734. doi: 10.1002/ijc.31865. Epub 2018 Dec 12. Int J Cancer. 2019. PMID: 30226269

6

Lnc2Cancer v2.0: updated database of experimentally supported long non-coding RNAs in human cancers.

Gao Y, Wang P, Wang Y, Ma X, Zhi H, Zhou D, Li X, Fang Y, Shen W, Xu Y, Shang S, Wang L, Wang L, Ning S, Li X. Gao Y, et al. Nucleic Acids Res. 2019 Jan 8;47(D1):D1028-D1033. doi: 10.1093/nar/gky1096. Nucleic Acids Res. 2019. PMID: 30407549 Free PMC article.

7

A comprehensive overview of oncogenic pathways in human cancer.

Li F, Wu T, Xu Y, Dong Q, Xiao J, Xu Y, Li Q, Zhang C, Gao J, Liu L, Hu X, Huang J, Li X, Zhang Y. Li F, et al. Brief Bioinform. 2020 May 21;21(3):957-969. doi: 10.1093/bib/bbz046. Brief Bioinform. 2020. PMID: 31155677 Review.

8

Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data.

Xu Y, Dong Q, Li F, Xu Y, Hu C, Wang J, Shang D, Zheng X, Yang H, Zhang C, Shao M, Meng M, Xiong Z, Li X, Zhang Y. Xu Y, et al. J Transl Med. 2019 Aug 6;17(1):255. doi: 10.1186/s12967-019-2010-4. J Transl Med. 2019. PMID: 31387579 Free PMC article.

9

Quantifying Risk Pathway Crosstalk Mediated by miRNA to Screen Precision drugs for Breast Cancer Patients.

Xu Y, Lin S, Zhao H, Wang J, Zhang C, Dong Q, Hu C, Desi S, Wang L, Xu Y. Xu Y, et al. Genes (Basel). 2019 Aug 28;10(9):657. doi: 10.3390/genes10090657. Genes (Basel). 2019. PMID: 31466383 Free PMC article.

10

Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines.

Wang L, Zhao H, Li J, Xu Y, Lan Y, Yin W, Liu X, Yu L, Lin S, Du MY, Li X, Xiao Y, Zhang Y. Wang L, et al. Oncogene. 2020 Jan;39(3):677-689. doi: 10.1038/s41388-019-1005-1. Epub 2019 Sep 19. Oncogene. 2020. PMID: 31537905 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

751 results

Search Page

Filters